Could early blood thinner save more heart attack patients?

NCT ID NCT07361783

Recruiting now Disease control Sponsor: Chen Jing Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at giving a blood thinner called heparin to heart attack patients as soon as they see a doctor, rather than waiting until they are in the procedure room. About 6,294 participants will be randomly assigned to early or standard timing. The goal is to see if early treatment reduces death, another heart attack, or stroke within 30 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: unfractionated heparin (a blood thinner)
What this could lead to: If it works, this could show that giving heparin earlier during a heart attack improves survival and reduces complications.
What could go wrong: This is a large trial, but it tests a timing change for an existing drug, not a new treatment. The benefit may be small, and there is a risk of bleeding from the blood thinner.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY PCI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY PCI ST-ELEVATION MYOCARDIAL INFARCTION (STEMI)

Contacts and locations

Locations

Renmin Hospital of Wuhan university
RECRUITING

Wuhan, Hubei, 430000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.